SITC Cancer Immunotherapy CONNECT

The CheckPoints

Crisis in Clinical Research Virtual Summit

SITC is convening key oncology experts to lead a conversation about limited patient access to clinical trials and slowed drug development. You are invited to listen in on Aug. 17, 2022.

Register Today

Develop Your Clinical Trial Protocol at the SCION Workshop
Jan. 17–21, 2023, in Austin, Texas

Selected participants will develop a cancer immunotherapy clinical trial protocol synopsis with guidance from expert faculty. 

APPLY NOW

SITC 2022 Logo.png

Register Now

Join us at our 37th Annual Meeting & Pre-Conference Programs on Nov. 8–12, 2022 at the Boston Convention & Exhibition Center in Boston, MA. Virtual participation also available.

REGISTER NOW

SITCMedscape

Comprehensive Learning Center: Year 8

Immunotherapy - A Revolutionary Approach for Difficult-to-Treat Cancers. CME activities developed through a partnership between Medscape and SITC.

Learn More

SITC CIG App Homescreen Cropped

Download the new SITC Clinical Practice Guidelines Mobile App!
The first and only immunotherapy-specific clinical practice guidelines app featuring expert panel recommendations. Available for FREE for iOS and Android.

Download Now

New SITC Clinical Practice Guidelines Published

Includes Acute Leukemia, Breast Cancer, Hepatocellular Carcinoma, Immune Checkpoint Inhibitor-related Adverse Events, Urothelial Cancer, & Nonmelanoma Skin Cancer. Free companion educational webinars available.

Learn more

Target for Cancer IO.png

Targets for Cancer IO: A Deep Dive Series

This highly anticipated series addresses key cancer IO questions in depth, and with top faculty leading the discussion. Register soon! Special offer available.

LEARN MORE

JITC Anniversary

Celebrate a Decade of Publishing with SITC’s Official Journal

Hear from editors about the state of the field, explore the journal’s major milestones, and read top content.

LET'S CELEBRATE!

icon-patients.png

For patients

Explore comprehensive resources and educational opportunities for cancer patients and those who advocate for them.

Explore

icon-stethoscope.png

For Clinicians

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.


Explore

icon-researcher.png

For Researchers

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.


Explore

Latest Discussions

  • We are excited to announce the virtual conference "Immunotherapy for Solid Organ Transplant Patients" . Cancer immunotherapy has become a standard therapy for many cancers, but its use in transplant patients is challenging because of safety and efficacy ...

  • With support of New PI Cell & Developmental Biology community, we are organizing a panel discussion event. Six New PIs from US and Europe will share their experiences in job market, lab set up and take questions from audience. Target audience: postdocs ...

  • Animal Models for Cancer Interception and Precision Prevention Virtual Workshop Sponsored by the Division of Cancer Prevention, and the Division of Cancer Biology, NCI Date : October 13-14, 2022 Workshop Objectives: The main ...

Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders
seeking toadvance research in the cancer immunotherapy field.

Learn More

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

  • Hello JITC Readers, Welcome to the latest edition of the JITC Digest. This month we are excited...
  • Hello JITC Readers, June is always a special month for the journal and our field as we celebrate...
  • Hello JITC Readers, This month’s JITC digest marks the beginning of the journal’s 10th anniversary...

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More